Liver indicators affecting the relationship between BMI and hypertension in type 2 diabetes: a mediation analysis.

Authors:
Yao X; Hu K; Wang Z; Lu F; Zhang J and 10 more

Journal:
Diabetol Metab Syndr

Publication Year: 2024

DOI:
10.1186/s13098-023-01254-z

PMCID:
PMC10792781

PMID:
38229128

Journal Information

Full Title: Diabetol Metab Syndr

Abbreviation: Diabetol Metab Syndr

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology & Metabolism

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThis study was approved by the Ethical Review Committee (Approval No: 2018-010) and was registered in the Chinese Clinical Trial Registry (ChiCTR1800014432). Each participant provided their written informed consent to participate in this study. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This research was funded by the Anhui Province Clinical Medical research transformation Project (202204295107020027) and National Natural Science Foundation of China (81970703)."

Evidence found in paper:

"Declarations: Ethics approval and consent to participateThis study was approved by the Ethical Review Committee (Approval No: 2018-010) and was registered in the Chinese Clinical Trial Registry (ChiCTR1800014432). Each participant provided their written informed consent to participate in this study.: Consent for publicationNot applicable.: Competing interestsThe authors declare no competing interests. Ethics approval and consent to participate: This study was approved by the Ethical Review Committee (Approval No: 2018-010) and was registered in the Chinese Clinical Trial Registry (ChiCTR1800014432). Each participant provided their written informed consent to participate in this study."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025